[b]CERP >> $500K NEW REVZZZ // Cereplast Announces $500,000 in New Revenue and Provides 2013 Outlook[/b]
2013-01-23 08:00 ET - News Release
EL SEGUNDO, Calif., Jan. 23, 2013 (GLOBE NEWSWIRE) -- Cereplast, Inc. (OTCQB:CERP) (the "Company"), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, today is providing a shareholder update and an outlook for 2013. Cereplast has created additional liquidity through the generation of approximately $500,000 in revenue over the last six weeks while continuing to focus on restructuring its operations to further position the Company for growth throughout 2013.
Revenue Generation in Europe, the United States and Asia
In Europe, specifically in Italy, the Italian parliament made a critical vote on December 13, 2012, which confirms the proposed sanctions on companies using traditional plastic bags and mandates a switch to bioplastic or other alternatives 60 days from the publication of the Application Decree. In anticipation of the final Application Decree to be signed, Cereplast has received several orders for blown film resin, which were fulfilled utilizing its existing inventory. All customer payments were received in advance of shipment or within conservative credit terms. The Company expects continued growth in demand for blown film as a result of the anticipated legislation in Italy.
In the United States, Cereplast received several orders for compostable resins that will be used for food service applications. Multiple large food chains have started to embrace the use of compostable material for food service ware items including straws, cups and cutlery, for which Cereplast's resins are in demand. Cereplast has fulfilled these orders and all payments have been received.
Cereplast received several purchase orders from existing clients in India. Management is encouraged by the progress made in India and anticipates their investments in this new market will translate into additional purchase orders and future revenue growth in 2013.
Debt and Indenture
Management announced that our debt holders have waived the event of default, and have agreed to forbear from exercising their rights and remedies under the Indenture with respect to the Company's failure to make interest payments due on June 1, 2012 and December 1, 2012. The Company was successful in arranging a structured investment from an institutional investor, offering a repayment plan to settle both the past due interest balance as well as the coupon due in June 2013. The restructuring provides the Company relief until December 2013.
With respect to the Compass Horizon term loan, an arrangement was completed by which an institutional investor will repay the remaining principal and interest owed under the Term Loan.
Working Capital and Liquidity
To provide the Company with the required working capital to continue operations, approximately $1 million in short term convertible debt and equity financing was completed. In order to maximize these new investments, the Company has enacted an operational restructuring strategy which includes a reduction in operating costs. Additionally, the Company has taken aggressive cost cutting measures, which include a furlough for production employees and a reduction in its worldwide headcount to 17 employees.
In order to improve cash flow, the Company adjusted their sales and shipment policy, requiring payment in advance of shipment and reducing terms to less than 30 days for large domestic companies.
Inventory Recovery from Delinquent Accounts Receivable
Cereplast initiated a systematic strategy to recover their customers' unsold inventories associated with their delinquent Accounts Receivable balances. In September 2012, 22 containers of the Company's Compostable resins were successfully recovered, valued at approximately $2 million. The same strategy will be used to recover available remaining assets across Europe, Italy, Germany and Malta.
Intellectual Property
Management believes that there is tremendous unlocked value within the intellectual property portfolio of the Company. As the industry continues to evolve, management believes that large conglomerates will begin to make further investments. It is therefore critical to continue to protect the Company's intellectual property while continuing key Research and Development projects. In 2012, Cereplast was granted two patents and is prepared to file an additional five patents in the next few weeks covering both families of resins: Cereplast Compostables® resins and Cereplast Sustainables® resins, including Cereplast Algae Bioplastics™.
About Cereplast, Inc.
Cereplast, Inc. (OTCQB:CERP) designs and manufactures proprietary biobased, sustainable bioplastics which are used as substitutes for traditional plastics in all major converting processes - such as injection molding, thermoforming, blow molding and extrusions - at a pricing structure that is competitive with traditional plastics. On the cutting-edge of biobased plastic material development, Cereplast now offers resins to meet a variety of customer demands. Cereplast Compostables® resins are ideally suited for single-use applications where high biobased content and compostability are advantageous, especially in the food service industry. Cereplast Sustainables® resins combine high biobased content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics and packaging. Learn more at www.cereplast.com. You may also visit the Cereplast social networking pages at Facebook.com/Cereplast, Twitter.com/Cereplast and Youtube.com/Cereplastinc.
The Cereplast, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9567
CONTACT: Cereplast, Inc.
Public Relations
Nicole Robertson
(310) 615-1900 x154
nrobertson@cereplast.com
Investor Relations:
Alliance Advisors, LLC
Alan Sheinwald
914-669-0222
asheinwald@allianceadvisors.net
www.AllianceAdvisors.net
CERP $500K NEW REVZZZ // Cereplast Announces $500,000 in
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Comprehensive Update on Voting Rights and Share Capital Status
URW SE stirred the pot back in September when they updated their voting rights and share capital. With a hefty total of 139,370,486 shares, this company is a real heavyweight in the European market. Shareholders can flex some serious muscle when it comes to company decisions. It's not just about holding shares; it's about wielding influence where it counts. Voting Rights:...
Continue Reading
Veteran Realtor Kate Johnson Earns Inner Circle Honor
Decades of Real Estate Mastery under Kate Johnson's Belt In a world where the real estate market twists and turns like a seasoned poker player, Kate Johnson stands tall as a beacon of consistency and trust. Over five decades—yes, you heard it right, more than 51 years—she's been slicing through the complexity of the residential real estate landscape like a hot knife...
Continue Reading
JPMorgan Supports Homeowners Affected by Wildfires
JPMorgan Chase Assists Homeowners During Wildfire Crisis In response to the recent wildfires impacting many communities, JPMorgan Chase (NYSE: JPM) has stepped up to offer significant support to its mortgage customers. The bank's home lending unit has introduced a disaster forbearance program specifically designed to assist homeowners affected by these devastating events....
Continue Reading
Investigation Launched on Brookline Bancorp Sale to Berkshire
Halper Sadeh LLC Investigates Brookline Bancorp's Sale In a significant move that has caught the attention of investors and financial experts alike, Halper Sadeh LLC has announced its investigation regarding the sale of Brookline Bancorp, Inc. (NASDAQ: BRKL) to Berkshire Hills Bancorp, Inc. This is regarding whether the terms of the sale—0.42 shares of Berkshire common...
Continue Reading
Investigating SARS-CoV-2: Understanding Orphan Genes Role
Orphan Genes and COVID-19 Severity The recent discoveries related to orphan genes in the SARS-CoV-2 virus signify a promising avenue for advancing our understanding of COVID-19. Researchers from an international collaborative team have identified an orphan gene within the virus that plays a crucial role in determining the severity of COVID-19. This research could not only...
Continue Reading